| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $145.8M | $127.6M | $102.0M |
| YoY Revenue Growth % | +14.3% | +25.1% | — |
| Gross Profit | $88.8M | $69.3M | — |
| Gross Margin % | 60.9% | 54.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$23.6M | -$46.3M | -$57.9M |
| Operating Margin % | -16.2% | -36.3% | -56.8% |
| Net Income (GAAP) | -$25.6M | -$48.5M | -$59.7M |
| EBITDA (Normalized) | -$19.9M | -$44.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $23.5M | $12.5M | -$7.3M |
| Capital Expenditures (CapEx) | $4.7M | $1.7M | — |
| Free Cash Flow (FCF) | $18.9M | $10.8M | -$7.3M |
| FCF Margin % | 12.9% | 8.5% | -7.2% |
| Return on Invested Capital (ROIC %) | -34.5% | -45.0% | — |
| Cash & Short-Term Equivalents | $29.2M | $45.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $83.2M | $77.6M | — |